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Abstract IMP was found to activate AMP deaminase in crude
glucose-depleted human erythrocyte lysates. Activation of the
enzyme by IMP is due to prevention of the inhibitory effect of
inorganic phosphate. At 1 mM AMP and 2^3 mM phosphate the
addition of 2^5 mM IMP accelerates the AMP deamination two
to three times.
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1. Introduction
In human erythrocytes, AMP deaminase (EC 3.5.4.6) irre-
versibly hydrolyses AMP to IMP. The enzyme is extremely
active (Vmax is about 200 mmol/h/l cells) [1^4]; thus, it appears
that the e¡ective regulation of AMP deamination in the cell is
important for the control of normal levels of adenylates, es-
pecially ATP. Despite extensive studies of the enzyme, its
speci¢c role in the cell and the mechanisms responsible for
its regulation are still unclear. Moreover, kinetic data ob-
tained on isolated AMP deaminase con£ict with results ob-
tained in vivo; the rate of AMP deamination extrapolated
from kinetic parameters determined for the isolated enzyme
at actual intracellular concentrations of AMP and in the pres-
ence of e¡ectors [1,3,5^9] is signi¢cantly greater than that
found in native erythrocytes [10^15]. This discrepancy may
result either from alteration of enzyme properties during pu-
ri¢cation or from the lack of some e¡ectors (which are present
in vivo) in the reaction mixtures used to study the isolated
AMP deaminase.
The aim of this work was to study the AMP deaminase of
erythrocytes under conditions closely simulating those which
exist intracellularly. Speci¢cally, the kinetics of AMP degra-
dation in crude lysates of erythrocytes was studied.
2. Materials and methods
2.1. Preparation of haemolysates
Healthy donor blood anticoagulated with CPD (citrate phosphate
dextrose solution) was centrifuged at 1500Ug for 10 min. The plasma
and the upper layer of cells containing platelets and leukocytes were
removed. The erythrocytes were washed three times by centrifugation
at 1500Ug for 10 min in four volumes of a solution containing 150
mM NaCl, 30 mM KCl, and 5 mg/l gentamicin (solution A). The
washed erythrocytes were resuspended in solution A to a haematocrit
of 40^50% and incubated at 37‡C for 24 h. After incubation, the
erythrocytes were washed three times with solution A, then two times
with solution B containing 150 mM KCl, 1 mM MgCl2, 10 mM Tris-
HCl, and 3 mM L-mercaptoethanol (pH 7.4), and resuspended in
solution B to a haematocrit of 50%. To lyse cells, dry saponin was
added to the suspension (¢nal concentration 5 mM) and the mixture
was incubated for 15 min. Cellular membranes were removed by cen-
trifugation at 3500Ug of 1 h.
2.2. Dialysis of haemolysate
For dialysis, a membrane with a molecular weight cut-o¡ of 12 kDa
(Sigma, USA) was used. 20 ml of haemolysate was dialysed against 1 l
of solution B at 4‡C for 12 h with permanent stirring.
2.3. Assay for AMP deaminase
Before the experiments, haemolysates were diluted with solution B
to a haemoglobin concentration of approximately 80 g/l. All incuba-
tions were carried out in te£on cells thermostatted at 37‡C with per-
manent stirring. AMP, inorganic phosphate, 2,3-diphosphoglycerate,
IMP, inosine and hypoxanthine were prepared as 10^100 mM stock
solutions in solution B.
The reaction was started by the addition of AMP (0.5^10 mM) to
2 ml of the haemolysate. The reaction was terminated by the addition
of two volumes of 0.5 M HClO4. The mixture was vigorously stirred
and centrifuged at 1500Ug for 10 min. The pH of the supernatant
was adjusted to 7.0 with a saturated solution of K2CO3. Three ali-
quots were withdrawn from the haemolysate: 0, 2, and 4 min after the
addition of AMP. The rate of AMP degradation was determined as
the di¡erence in AMP concentrations between the zero time and sub-
sequent samples and was expressed as mmol AMP hydrolysed per h
per litre of cells. We assumed that 1 l of erythrocytes contains 300 g of
haemoglobin [16].
2.4. Determinations of metabolite concentrations
The perchloric acid extracts were analysed by HPLC [17]. The con-
centration of haemoglobin was determined spectrophotometrically at
416 nm. The inorganic phosphate was determined using a phosphorus
test kit from Kone (Finland).
3. Results
Fig. 1 shows the dependence of the initial rate of AMP
degradation on the concentration of AMP (VAMP) in crude
haemolysates. Analysis of the Lineweaver-Burk and Hill plots
revealed a sigmoidal curve with n = 2.3, Vmax = 100 mmol/h/l
cells, and S0:5 = 4 mM (data of four experiments). IMP was a
major product of AMP degradation, suggesting that AMP
deamination was largely responsible for the shape of VAMP.
Fig. 1 shows the initial rates of AMP degradation (open
circles) and those after 2 min of preincubation with AMP
(solid circles). After 2 min of preincubation, AMP degrada-
tion products (IMP, inosine and hypoxanthine) were formed,
and their stimulatory e¡ect on AMP deamination became
evident.
The substrate rate dependences for AMP degradation in the
presence of IMP, inosine or hypoxanthine shown in Fig. 2
suggest that IMP is an activator of AMP deaminase.
Fig. 3 shows the e¡ects of IMP and inorganic phosphate
added to a dialysed haemolysate on the VAMP. Without the
e¡ectors, VAMP appears as a simple hyperbolic function, with
Km and Vmax of about 6 mM and 200 mmol/h/l cells, respec-
tively. These results are consistent with those obtained for
isolated enzyme under the same conditions [6,8,9]. IMP was
ine¡ective when added to the dialysed haemolysate. This ob-
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servation suggested that crude haemolysates contained some
low-molecular-weight inhibitor of AMP deaminase whose ef-
fect was abolished by added IMP. Thus, the e¡ect of IMP on
AMP deaminase inhibited by 2,3-diphosphoglycerate or inor-
ganic phosphate was studied (Table 1). IMP activated the
enzyme in dialysed haemolysate containing inorganic phos-
phate and showed no e¡ect in the presence of 2,3-diphospho-
glycerate.
4. Discussion
Lushchak and Storey have shown that IMP inhibits puri¢ed
AMP deaminase from the salmon white muscle [18]. In con-
trast, we found that IMP stimulates the enzyme in crude er-
ythrocyte lysates, but does not a¡ect AMP deaminase in dia-
lysed haemolysates. This observation suggests that a low-
molecular-weight inhibitor of AMP deaminase exists in crude
haemolysates, and IMP acts by diminishing its e¡ect. Our
data on the combined e¡ect of IMP and inorganic phosphate
on AMP deaminase suggest that inorganic phosphate is likely
to be such an inhibitor. Crude haemolysates contain 1.5^2.5
mM orthophosphate; at a concentration of 1 mM, AMP was
deaminated at a rate of about 5 mmol/h/l cells (Figs. 1 and 2).
The same rate was observed in the dialysed haemolysates
containing 2^3 mM KH2PO4 (Table 1). In both cases, 5 mM
IMP accelerated AMP deamination two to three times. We
believe that IMP and inorganic phosphate compete for the
common binding site on the AMP deaminase molecule. IMP
had no e¡ect on the inhibition of AMP deaminase by 2,3-
diphosphoglycerate. This observation needs further studying
because inorganic phosphate and 2,3-diphosphoglycerate bind
to the same site on the AMP deaminase [7,19,20].
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Fig. 1. Rate of AMP degradation in crude erythrocyte lysates plot-
ted agains AMP concentration: (1) the initial rate and (2) the rate
determined 2 min after addition of AMP.
Fig. 2. Initial rate of AMP degradation in crude erythrocyte lysates
as a function of AMP concentration: (1) control, (2) 5 mM IMP,
(3) 2 mM inosine or (4) 4 mM hypoxanthine. The e¡ectors were
added simultaneously with AMP.
Table 1
E¡ect of IMP on the AMP degradation rate in the presence of 2,3-diphosphoglycerate or inorganic phosphate in dialysed haemolysates
Inhibitor IMP concentration Rate of AMP degradation (mmol/h/l cells)
^ ^ 15.1 þ 1.0 (2)
^ 5 mM 15.3 þ 2.0 (3)
KH2PO4 2 mM ^ 5.7 þ 0.9 (2)
^ 5 mM 9.8 þ 1.0 (2)
2,3-Diphosphoglycerate 3 mM ^ 2 þ 0.1 (2)
^ 5 mM 1.9 þ 0.2 (2)
The initial AMP concentration was 1 mM. The data shown are representative of three experiments. Means þ S.D.; numbers of measurements are
indicated in parentheses.
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Our results emphasise that it is di⁄cult to understand how
AMP deaminase is regulated within the cells by studying the
isolated enzyme: many intracellular e¡ectors exist and the net
e¡ect on AMP deaminase activity depends on their interplay.
Activation of AMP deaminase by IMP results in a positive
feedback in the AMP degradation pathway. If the intracellu-
lar AMP level increases (e.g. when cell membrane damage
signi¢cantly activates transporting ATPases), this positive
feedback would result in an irreversible, self-accelerated ad-
enylate pool loss. Eventually, this will lead to cell death.
Under normal physiological conditions, when the rate of
AMP degradation is low (40^60 mmol/h/l cells [10^15]) and
the IMP concentration is about 0.01 mM [21,22], the product
activation of AMP deaminase has no e¡ect on erythrocyte
metabolism. We believe that the product activation of AMP
deaminase may serve as the mechanism for elimination of
severely damaged cells.
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Fig. 3. Substrate rate dependence of AMP degradation in dialysed
erythrocyte lysates: (1) control, (2) 5 mM IMP or (3) 5 mM
KH2PO4. Inorganic phosphate was added 30 min before the addi-
tion of AMP; IMP was added simultaneously with AMP.
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